Maine, C. J., Miyake-Stoner, S. J., Spasova, D. S., Picarda, G., Chou, A. C., Brand, E. D., Olesiuk, M. D., Domingo, C. C., Little, H. J., Goodman, T. T., Posy, J. L., Gonzalez, J., Bayone, T. L., Sparks, J., Gary, E. N., Xiang, Z., Tursi, N. J., Hojecki, C. E., Ertl, H. C. J., Weiner, D. B., Casmil, I. C., Blakney, A. K., Essink, B., Somodevilla, G., Wang, N. S., Geall, A. J., Goldberg, Z., Aliahmad, P. (2025). Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers. Nature Communications. https://doi.org/10.1038/s41467-025-55843-9